Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Receives Consensus Rating of “Buy” from Analysts
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) has been assigned an average recommendation of “Buy” from the six analysts that are covering the company, MarketBeat.com reports. Six investment analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokers that have issued a report on the stock in the […]
More Stories
Trump Signs ‘Big, Beautiful Bill’ Into Law During July 4 Celebration
By Emel Akan WASHINGTON—President Donald Trump signed the One Big Beautiful Bill Act into law on July 4, celebrating both...
Hurricanes Land Last Big-Name Free Agent in Nik Ehlers
By Matthew Davis The Carolina Hurricanes made one of the biggest signings of the NHL offseason on Thursday by landing...
Federal Reserve Rates Are Too High, Says Former World Bank Chief
By Naveen Athrappully Former World Bank President David Malpass criticized the U.S. Federal Reserve for keeping its benchmark interest rate...
Fall For Me: Netflix’s Erotic Thriller Premieres August 2025
Netflix is all set to welcome an epic German erotic thriller, Fall For Me, that is sure to make the...
Independence Day: A Reflection on the Past, A Warning for the Future
By Stephen Zogopoulos, USNN World News The Meaning of Independence Day: Then and Now Every July 4th, Americans gather to...
8tshare6a Software Download Guide: Features, Safety, and Alternatives
There are numerous software programs available online for various purposes, some of which are useful and some of which are...